BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

173 related articles for article (PubMed ID: 36610353)

  • 21. β4GALT1 controls β1 integrin function to govern thrombopoiesis and hematopoietic stem cell homeostasis.
    Giannini S; Lee-Sundlov MM; Rivadeneyra L; Di Buduo CA; Burns R; Lau JT; Falet H; Balduini A; Hoffmeister KM
    Nat Commun; 2020 Jan; 11(1):356. PubMed ID: 31953383
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of Tropomyosin Receptor Kinase A Signaling Negatively Regulates Megakaryopoiesis and induces Thrombopoiesis.
    Kizilyer A; Singh MV; Singh VB; Suwunnakorn S; Palis J; Maggirwar SB
    Sci Rep; 2019 Feb; 9(1):2781. PubMed ID: 30808933
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mammalian target of rapamycin (mTOR) regulates both proliferation of megakaryocyte progenitors and late stages of megakaryocyte differentiation.
    Raslova H; Baccini V; Loussaief L; Comba B; Larghero J; Debili N; Vainchenker W
    Blood; 2006 Mar; 107(6):2303-10. PubMed ID: 16282343
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition of TPO-induced MEK or mTOR activity induces opposite effects on the ploidy of human differentiating megakaryocytes.
    Guerriero R; Parolini I; Testa U; Samoggia P; Petrucci E; Sargiacomo M; Chelucci C; Gabbianelli M; Peschle C
    J Cell Sci; 2006 Feb; 119(Pt 4):744-52. PubMed ID: 16449323
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Critical role for ERK1/2 in bone marrow and fetal liver-derived primary megakaryocyte differentiation, motility, and proplatelet formation.
    Mazharian A; Watson SP; Séverin S
    Exp Hematol; 2009 Oct; 37(10):1238-1249.e5. PubMed ID: 19619605
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Photobiomodulation therapy for thrombocytopenia by upregulating thrombopoietin expression via the ROS-dependent Src/ERK/STAT3 signaling pathway.
    Wang Q; Chang H; Shen Q; Li Y; Xing D
    J Thromb Haemost; 2021 Aug; 19(8):2029-2043. PubMed ID: 33501731
    [TBL] [Abstract][Full Text] [Related]  

  • 27. DMAG, a novel countermeasure for the treatment of thrombocytopenia.
    Lin J; Zeng J; Liu S; Shen X; Jiang N; Wu YS; Li H; Wang L; Wu JM
    Mol Med; 2021 Nov; 27(1):149. PubMed ID: 34837956
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An amphipathic motif at the transmembrane-cytoplasmic junction prevents autonomous activation of the thrombopoietin receptor.
    Staerk J; Lacout C; Sato T; Smith SO; Vainchenker W; Constantinescu SN
    Blood; 2006 Mar; 107(5):1864-71. PubMed ID: 16249382
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Thrombopoietin receptor agonist antibody for treating chemotherapy-induced thrombocytopenia.
    Shin J; Kim MJ; Quan X; Kim JW; Lee S; Park S; Jeong JY; Yea K
    BMC Cancer; 2023 May; 23(1):490. PubMed ID: 37259024
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Preclinical activity of eltrombopag (SB-497115), an oral, nonpeptide thrombopoietin receptor agonist.
    Erickson-Miller CL; Delorme E; Tian SS; Hopson CB; Landis AJ; Valoret EI; Sellers TS; Rosen J; Miller SG; Luengo JI; Duffy KJ; Jenkins JM
    Stem Cells; 2009 Feb; 27(2):424-30. PubMed ID: 19038790
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The combination of machine learning and transcriptomics reveals a novel megakaryopoiesis inducer, MO-A, that promotes thrombopoiesis by activating FGF1/FGFR1/PI3K/Akt/NF-κB signaling.
    Zhang T; Mo Q; Jiang N; Wu Y; Yang X; Chen W; Li Q; Yang S; Yang J; Zeng J; Huang F; Huang Q; Luo J; Wu J; Wang L
    Eur J Pharmacol; 2023 Apr; 944():175604. PubMed ID: 36804544
    [TBL] [Abstract][Full Text] [Related]  

  • 32. hGH promotes megakaryocyte differentiation and exerts a complementary effect with c-Mpl ligands on thrombopoiesis.
    Xu Y; Wang S; Shen M; Zhang Z; Chen S; Chen F; Chen M; Zeng D; Wang A; Zhao J; Cheng T; Su Y; Wang J
    Blood; 2014 Apr; 123(14):2250-60. PubMed ID: 24553176
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dynamin 2-dependent endocytosis is required for normal megakaryocyte development in mice.
    Bender M; Giannini S; Grozovsky R; Jönsson T; Christensen H; Pluthero FG; Ko A; Mullally A; Kahr WH; Hoffmeister KM; Falet H
    Blood; 2015 Feb; 125(6):1014-24. PubMed ID: 25468568
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Development of Romiplostim for Treatment of Primary Immune Thrombocytopenia From a Pharmacokinetic and Pharmacodynamic Perspective.
    Yang BB; Doshi S; Arkam K; Franklin J; Chow AT
    Clin Pharmacokinet; 2016 Sep; 55(9):1045-58. PubMed ID: 27056734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Miniaturized 3D bone marrow tissue model to assess response to Thrombopoietin-receptor agonists in patients.
    Di Buduo CA; Laurent PA; Zaninetti C; Lordier L; Soprano PM; Ntai A; Barozzi S; La Spada A; Biunno I; Raslova H; Bussel JB; Kaplan DL; Balduini CL; Pecci A; Balduini A
    Elife; 2021 Jun; 10():. PubMed ID: 34059198
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transcriptional characterization of human megakaryocyte polyploidization and lineage commitment.
    Choudry FA; Bagger FO; Macaulay IC; Farrow S; Burden F; Kempster C; McKinney H; Olsen LR; Huang N; Downes K; Voet T; Uppal R; Martin JF; Mathur A; Ouwehand WH; Laurenti E; Teichmann SA; Frontini M
    J Thromb Haemost; 2021 May; 19(5):1236-1249. PubMed ID: 33587817
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Platelet-derived growth factor enhances platelet recovery in a murine model of radiation-induced thrombocytopenia and reduces apoptosis in megakaryocytes via its receptors and the PI3-k/Akt pathway.
    Ye JY; Chan GC; Qiao L; Lian Q; Meng FY; Luo XQ; Khachigian LM; Ma M; Deng R; Chen JL; Chong BH; Yang M
    Haematologica; 2010 Oct; 95(10):1745-53. PubMed ID: 20562316
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Linkage between the mechanisms of thrombocytopenia and thrombopoiesis.
    Eto K; Kunishima S
    Blood; 2016 Mar; 127(10):1234-41. PubMed ID: 26787737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Increased megakaryocytopoiesis in Lyn-deficient mice.
    Lannutti BJ; Minear J; Blake N; Drachman JG
    Oncogene; 2006 Jun; 25(23):3316-24. PubMed ID: 16418722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Structure of the thrombopoietin-MPL receptor complex is a blueprint for biasing hematopoiesis.
    Tsutsumi N; Masoumi Z; James SC; Tucker JA; Winkelmann H; Grey W; Picton LK; Moss L; Wilson SC; Caveney NA; Jude KM; Gati C; Piehler J; Hitchcock IS; Garcia KC
    Cell; 2023 Sep; 186(19):4189-4203.e22. PubMed ID: 37633268
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.